Pharmafile Logo

Lexington Health

Lexington Health is a dedicated practice within Lexington Communications with specialist knowledge of healthcare communications and engagement. Our team combines extensive expertise in health policy and campaigns as well as press and digital communication, backed by senior counselling skills honed in our role as strategic advisers to leading global corporations and organisations. Our clients include major blue-chip companies, trade unions, campaign and patient advocacy groups and charities. Lexington Health’s knowledge and experience in strategic communications, and our detailed understanding of the healthcare, biopharmaceutical and medical technologies landscape, enables us to assist clients in dealing with the difficult and complex issues facing their organisations. We understand the need for concise, consistent and coherent communications and engagement and help our clients to secure maximum coverage for their messages among policymakers, politicians, the media, patient groups, clinicians, the public and wider stakeholder groups. Lexington Health also works at an international level, supporting clients across the globe. We have coordinated various campaigns not only in Europe but have also coordinated projects spanning different continents.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

The Connection 198 High Holborn, London, WC1V 7BD

 Latest Content from PMHub 

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Press Releases | January 7, 2026 | Inizio

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Five Predictions That Will Reshape Biopharma Commercialisation in 2026

White Papers and Resources | January 5, 2026 | Nmblr

Every year, we’re met with restructuring, hiring freezes, and portfolio cuts. And every year we tell ourselves the same story. It’s a rough patch. A cycle that will reverse. But...

Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?

Press Releases | December 23, 2025 | Medscape Education

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.

Does Rare Disease Education Work?

Press Releases | December 23, 2025 | Medscape Education

For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.

From Genetic Puzzles to Precision Therapeutics

Press Releases | December 23, 2025 | Medscape Education

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...

Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series

Press Releases | December 23, 2025 | Medscape Education

Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to empower them to meet the...

What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?

Press Releases | December 23, 2025 | Medscape Education

Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We...

Pharma’s digital dilemma: Finding the balance between speed, scale, and experience

What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der Heiden (AstraZeneca) argued it starts with design systems. This quick...